You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 8, February 24, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Abstract
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (254)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Pediatrics
 •Adolescent Medicine
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prevalence and Extent of Atherosclerosis in Adolescents and Young Adults

Implications for Prevention From the Pathobiological Determinants of Atherosclerosis in Youth Study

Jack P. Strong, MD; Gray T. Malcom, PhD; C. Alex McMahan, PhD; Richard E. Tracy, MD, PhD; William P. Newman III, MD; Edward E. Herderick; J. Fredrick Cornhill, DPhil; for the Pathobiological Determinants of Atherosclerosis in Youth Research Group

JAMA. 1999;281:727-735.

ABSTRACT

Context  Atherosclerosis, the underlying cause of coronary heart disease, has been shown to be present even in young adults.

Objective  To document the extent and severity of atherosclerosis in adolescents and young adults in the United States.

Design and Setting  The Pathobiological Determinants of Atherosclerosis in Youth Study, a multi-institutional autopsy study conducted in US medical centers.

Subjects  A total of 2876 study subjects, between 15 and 34 years old, black and white, men and women, who died of external causes and underwent autopsy between June 1, 1987, and August 31, 1994.

Main Outcome Measures  Extent, prevalence, and topography of atherosclerotic lesions.

Results  Intimal lesions appeared in all the aortas and more than half of the right coronary arteries of the youngest age group (15-19 years) and increased in prevalence and extent with age through the oldest age group (30-34 years). Fatty streaks were more extensive in black subjects than in white subjects, but raised lesions did not differ between blacks and whites. Raised lesions in the aortas of women and men were similar, but raised lesions in the right coronary arteries of women were less than those of men. The prevalence of total lesions was lower in the right coronary artery than in the aorta, but the proportion of raised lesions among total lesions was higher in the right coronary artery than in the aorta.

Conclusions  Atherosclerosis begins in youth. Fatty streaks and clinically significant raised lesions increase rapidly in prevalence and extent during the 15- to 34-year age span. Primary prevention of atherosclerosis, as contrasted with primary prevention of clinically manifest atherosclerotic disease, must begin in childhood or adolescence.



INTRODUCTION
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

This article summarizes the natural history of aortic and coronary atherosclerosis among adolescents from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study, which was a multi-institutional study of atherosclerosis in 15- to 34-year-old, black and white men and women who underwent autopsy.1-2 In 1986, THE JOURNAL republished, as a landmark article, the 1953 report by Enos et al3-4 of atherosclerosis in young American soldiers killed in the Korean War. A perspective of this landmark article traced the history of atherosclerosis in young persons prior to this landmark article up until the beginning of the PDAY Study.5 The present report closes the loop from the landmark article by presenting final results from the PDAY Study on the natural history of atherosclerosis in youth and young adulthood as viewed from a study of gross specimens.

The PDAY Study focused on 15- to 34-year-old subjects because fatty streaks are prevalent and fibrous plaques begin to appear in this age group.6-7 Due to continued lipid deposition and proliferation of smooth muscle and connective tissue, fatty streaks and fibrous plaques increase in size and extent and some undergo qualitative changes. The most serious change is rupture, which exposes the blood to lipid-rich thrombogenic material and precipitates an occlusive thrombus, which in turn leads to myocardial infarction or sudden cardiac death.8 The PDAY Study encompassed the transition from innocuous fatty streaks to clinically significant fibrous plaques and attempted to determine the conditions associated with this process.

Previous PDAY reports have described selected aspects of the effects of age, sex, race, serum lipoprotein levels, smoking, hypertension, glycohemoglobin levels, and obesity on the gross extent and microscopic characteristics of atherosclerotic lesions in these subjects.9-16 In brief, the conditions that predict risk of clinically manifest coronary heart disease (CHD) are also associated with the extent and severity of atherosclerosis in youth. This article summarizes the natural history of the grossly detectable lesions of atherosclerosis in American youth and confirms the rapid progression of atherosclerosis in some young adults examined at autopsy between 1987 and 1994.


METHODS
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Detailed descriptions of methods have been published in earlier reports.1-2,12-14,16 Nine cooperating centers adopted a standard operating protocol and a manual of procedures to collect specimens and information and to submit them to central laboratories for processing, artery grading, and analysis.1 Study subjects were persons aged 15 through 34 years who had died due to external causes and underwent autopsy in 1 of the cooperating medical examiners' laboratories between June 1, 1987, and August 31, 1994. Of the 3210 cases collected, 334 were excluded because they did not meet the study criteria. Of the 2876 cases included in this report, thoracic aortas were obtained from 2856, abdominal aortas from 2823, and right coronary arteries from 2788.

At the time of autopsy, the PDAY team bisected the descending thoracic and abdominal aorta longitudinally, prepared the right half for histological and chemical analyses, and fixed the left half in 10% neutral buffered formalin. The PDAY team opened and fixed the right coronary artery in the same manner as the aorta. The left anterior descending coronary artery was fixed by pressure perfusion for microscopic study. The left circumflex coronary artery was prepared for chemical and microscopic study.

Blood, liver, kidney tissue, and standardized arterial wall samples, including samples from the perfusion-fixed left anterior descending coronary artery, were also collected in this study. These samples were used to investigate the associations of atherosclerosis with the risk factors for adult CHD, which are reported elsewhere,9, 12-16 and for studies of the microscopic features of aortic and coronary lesions including cellular, fibrous, and lipid-containing components.10-11

Collection centers shipped the left half of each aorta and the right coronary artery in a plastic bag to the central laboratory. The central laboratory stained the arteries with Sudan IV17 and then x-ray films were made.

Three pathologists, blinded to specimen source or other information, independently evaluated the stained right coronary arteries and left halves of the aortas. They visually estimated the extent of intimal surface involved with fatty streaks, fibrous plaques, complicated lesions, and calcified lesions by procedures developed in the International Atherosclerosis Project.17 The sum of the percentages of surface involved with fibrous plaques, complicated lesions, and calcified lesions by gross visual grading was designated raised lesions. Consensus grading of lesions was the average of the 3 independent gradings.

The prevalence of cases with lesions was based on the recording by any of the pathologists of any nonzero value of percentage surface area involved from all lesion types except calcification. Prevalence also was computed based on 5% or greater surface area involved. Prevalence of calcified lesions was based on evaluation of the x-ray films.

The effects of sex, race, and 5-year age group on percentage surface area involved with lesions were analyzed using analysis of variance.18 The prevalence of cases involved with lesions was analyzed using multiple logistic regression.19

Macroscopic color transparencies and black-and-white prints of aortas and right coronary arteries on each case were sent to the Laboratory of Vascular Diseases at Ohio State University, Columbus, where an automated image processing system mapped the topographic distribution of atherosclerotic lesions in each artery as described previously.20-22 The image of the aorta and right coronary artery in 35-mm slides was digitized and transformed to standard templates. The standard templates were generated from the average location of the anatomical landmarks, such as ostia or branches of other arteries. The digitized images were used to compute lesion prevalence (percentage) at each pixel location and to generate maps. This process was performed for fatty streaks as identified by Sudan IV staining and raised atherosclerotic lesions as identified by pathologists at the Louisiana State University Medical Center, New Orleans.


RESULTS
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Table 1 shows the 2876 cases listed by sex, race, 5-year age group, and circumstances of death. The most frequent cause of death in white subjects was accidents; in black subjects, homicide. The mean percentage of intimal surface area involved with atherosclerotic lesions did not differ significantly among the causes of death within sex or race groups (results not shown). Therefore, all analyses were performed by pooling individuals dying of all causes.


View this table:
[in this window]
[in a new window]
Table 1. Cases Listed by Sex, Race, Age, and Cause of Death


Extent of Arterial Lesions

Table 2 shows the percentage of intimal surface area involved with atherosclerotic lesions by sex, race, and 5-year age groups for each arterial segment. Mean percentage of area involved with total lesions increased with age (P<.001) and was greater in blacks than in whites in all arterial segments (P<.001). Mean percentage of total lesion area was greater in men than in women for the thoracic aorta (P = .004) and less in men than in women for the abdominal aorta (P<.001). For the right coronary artery, men had greater total surface involvement than women (P<.001).


View this table:
[in this window]
[in a new window]
Table 2. Percent of Intimal Surface Area Involved With All Lesions and With Raised Lesions Only Listed by Sex, Race, and Age*


Mean percentage of area involved with raised lesions also increased with age (P<.001) in all arterial segments but did not differ greatly between blacks and whites in any of the arterial segments. Men and women had a similar extent of raised lesions in both aortic segments, but men had more extensive raised lesions than women (P<.001) in the right coronary artery. Although there were a few statistically significant interactions among sex, race, and age in their effects on extent and prevalence of lesions, these interactions were small and considered not to be biologically important.

Figure 1 illustrates the percentage of surface area involved with fatty streaks and raised lesions, which combine to form total surface area involved with lesions, by age, sex, and race. Fatty streaks account for the race difference (blacks more than whites) in all arterial segments. While fatty streaks also account for the sex difference in percentage of surface area involved in the aorta (thoracic, men more than women; abdominal, women more than men), raised lesions account for the sex difference in the right coronary artery; men have a greater extent of advanced lesions than women. The right coronary artery has a smaller percentage of surface involved with atherosclerotic lesions than either the thoracic or abdominal aorta, but a much greater proportion of lesions in the coronary artery are advanced lesions than in the thoracic or abdominal aorta.



View larger version (31K):
[in this window]
[in a new window]
Figure 1. Percentage of Intimal Surface Area Affected

Fatty streaks and raised lesions for the thoracic and abdominal aorta and the right coronary artery listed by sex, race, and 5-year age groups.


Prevalence of Arterial Lesions

Table 3 shows the prevalence of any atherosclerotic lesions and the prevalence of lesions involving more than 5% of the intimal surface area. All subjects in this study had lesions in the abdominal aorta, and all except 2 white men had lesions in the thoracic aorta. Prevalence of lesions in the right coronary artery increased from about 60% in the youngest age group to greater than 80% in men and approximately 70% in women in the 30- to 34-year age group (P<.001).


View this table:
[in this window]
[in a new window]
Table 3. Cases Having Any Lesions and 5% or Greater of Intimal Surface Area Involved With All Lesions and With Raised Lesions Only by Sex, Race, and Age*


The prevalence of total lesions involving 5% or more of the arterial surface was greater in women than men in the abdominal aorta (P = .01) and was greater in blacks than whites in the right coronary artery (P<.001).

The prevalence of raised lesions, whether measured as any lesions or lesions involving 5% or more of the arterial surface area, increased with age in all arterial segments of all sex and race groups. Prevalence of raised lesions by both measures was greater in the right coronary arteries of men than in those of women (P<=.003), but there were no differences in prevalence in the right coronary arteries between blacks and whites.

Table 4 shows the prevalence of lesions divided into fatty streaks, fibrous plaques, complicated lesions, and calcified lesions. Although complicated and calcified lesions were rare among these cases, all race-sex groups with subjects aged 30 to 34 years had some cases with calcified lesions in the abdominal aorta and right coronary artery, and all race-sex groups with subjects aged 30 to 34 years had some cases with complicated lesions, except for the right coronary artery in white women.


View this table:
[in this window]
[in a new window]
Table 4. Prevalence of Fatty Streaks, Fibrous Plaques, and Complicated Lesions as Determined by Pathologists' Evaluation of Gross Specimens and Evaluation of Calcified Lesions Using Soft Tissue Radiography by Sex, Race, and Age


Figure 2 shows the topographic distribution and prevalence of fatty streaks and raised lesions in the thoracic and abdominal aorta and Figure 3 shows the right coronary artery by 5-year age groups for people (black and white, men and women) aged 15 to 34 years. Some regions of the arteries were lesion prone, while others were lesion resistant. These prevalence maps also show the differences in the propensity to develop raised or advanced lesions among the 3 arteries.



View larger version (172K):
[in this window]
[in a new window]
Figure 2. Prevalence Maps of Fatty Streaks and Raised Lesions for the Left Halves of the Thoracic Aorta and the Abdominal Aorta

The maps for fatty streaks are displayed in banded isopleths. The maps for raised lesions are displayed in expanded banded isopleths.




View larger version (57K):
[in this window]
[in a new window]
Figure 3. Prevalence Maps of Fatty Streaks and Raised Lesions for the Right Coronary Artery

The maps for fatty streaks and raised lesions are displayed in expanded isopleths.


In the thoracic aorta, the highest prevalence of fatty streaks occurred in the dorsal surface (>50%) while the ventral surface had few fatty streaks (<10%). The region of highest prevalence for fatty streaks was midway between successive pairs of intercostal ostia. The thoracic aorta was virtually spared of raised lesions even in the oldest age group (30-34 years: <4% raised lesions).

In the abdominal aorta, the frequency of fatty streaks was greater in the dorsal than in the ventral area, but lesion-prone and lesion-resistant regions were not as sharply defined as in the thoracic aorta. Regions of high prevalence occurred between pairs of lumbar ostia and in flow tracts to the celiac, superior mesenteric, renal, and inferior mesenteric arteries, while regions distal to the flow dividers of these ostia were spared. A region on the left dorsal surface of the abdominal aorta, originating at the level of the inferior mesenteric ostium and extending distally to the bifurcation, was the most prone to raised lesions.

In the right coronary artery, fatty streaks formed a pattern with the highest prevalence of lesions in the proximal region. The highest prevalence of raised lesions was in the first 2 cm of the vessel. This distribution confirms that there are also lesion-prone and lesion-resistant regions of the coronary artery.


COMMENT
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Historical Perspective

For many years, investigators in the United States and abroad recognized the existence of atherosclerosis in children and adolescents, particularly in the aorta.23-27 The 1953 report of advanced lesions in the coronary arteries of young soldiers (average age, 22 years)3 surprised the medical community and focused attention on the potential importance of the childhood origin of atherosclerosis.

Holman and colleagues28 in New Orleans had already initiated studies on the natural history of atherosclerosis in children before the 1953 report by Enos et al3 was published and confirmed the presence of fatty streaks in the aorta in the first decade of life28 and in the coronary arteries in the second decade.29 Fibrous plaques appeared in the second decade in both arteries. These early observations, coupled with the emerging evidence that dietary fat and cholesterol were important determinants of plasma cholesterol concentrations, which contributed to the progression of atherosclerosis, led Holman30 to propose in 1959 that atherosclerosis was a pediatric nutrition problem. In subsequent years, evidence continued to show that atherosclerosis did begin in childhood.31-33 Strong and McGill6 examined the aortic and coronary artery lesions in 4737 persons, aged 10 to 39 years, from 6 geographic ethnic groups that represented a wide range in severity and extent of atherosclerosis. All aortas from all groups had fatty streaks. Fatty streaks were present in the coronary arteries of all subjects from New Orleans (a high atherosclerosis group) older than 20 years; and in 90% of the persons from other groups (all low atherosclerosis groups).6 Fibrous plaques appeared in a few coronary arteries before age 20 years, and prevalence and extent increased in the third and fourth decades.6

The PDAY results described in this report have confirmed and extended the previous observations concerning the ubiquity of fatty streaks in the abdominal aortas of adolescents and young adults and the frequency of fibrous plaques in the aortas and coronary arteries of young adults in a diverse sample of the US population during the current decade.

Fatty Streak and the Fibrous Plaque (Raised Lesion)

One of the objectives of the PDAY Study was to examine in greater depth the relationship of the fatty streak in young persons to the fibrous plaque and complicated lesions in older persons. The question of whether fibrous plaques arise from fatty streaks, or whether they arise independently of fatty streaks, has been a controversial issue in the pathogenesis of atherosclerosis. The PDAY results presented herein show that fatty streaks in some locations—the thoracic aorta and portions of the ventrolateral intimal surface of the abdominal aorta—are not likely to be replaced by raised lesions during the 15- to 34-year age period (Figure 2). On the other hand, the distribution pattern of raised lesions in the dorsolateral portion of the abdominal aorta (Figure 2) and the distribution pattern of raised lesions in the right coronary artery of older persons ( Figure 3) follow those of the distribution of fatty streaks in younger persons.

Among the most persuasive evidence for the fatty streak being the precursor of the raised lesions is that derived from the microscopic examination of lesions of the coronary arteries. Stary,34-35 using light and electron microscopy of the unopened pressure perfusion-fixed left coronary arteries, studied 691 men and women who died between full-term birth and age 39 years to assess the earliest microscopic changes of atherosclerosis. More than 50% of children aged 10 to 14 years had lesions characterized by accumulations of macrophage foam cells, lipid-containing smooth muscle cells, and thinly scattered extracellular lipid. These changes represent the microscopic counterpart of gross fatty streaks. Approximately 8% of the subjects, aged 10 to 14 years, had lesions with larger accumulations of extracellular lipid that were thought to be in transition to fibrous plaques (ie, the lesions that are known to be associated with clinical disease in adults). These results indicate a progression from fatty streaks through intermediate or transitional lesions to atheromatous lesions (comparable with fibrous plaques by gross classification) in a defined segment of the left anterior descending coronary artery that is predisposed to clinically significant lesions.

Other evidence linking the fatty streak to the raised lesions includes topographic, chemical, physical chemical, and other histologic studies.36-44 These studies are consistent with Stary's34-35 demonstration of a continuous spectrum of lesions that begin with a collection of lipid-filled macrophages and progress to a lesion with a core of necrotic debris, extracellular lipid, and a fibromuscular cap, which is the typical raised lesion that directly leads to thrombotic occlusion and CHD. These results suggest that, although fatty streaks may be innocuous if they remain as such, under certain conditions and at certain anatomic sites, they represent the first stage of a process leading to clinical disease.

Secular Trends. In the International Atherosclerosis Project (1960-1964) and earlier studies of the natural history in New Orleans, white men consistently had more extensive coronary artery raised lesions than black men.29, 45 This pattern was altered in the Community Pathology Study of atherosclerosis in New Orleans in the 1970s. In 25- to 44-year-old men, the extent of raised coronary lesions was approximately the same in black and white subjects.46-48 Comparisons with the International Atherosclerosis Project results suggested that coronary atherosclerotic lesions had decreased in white men and remained relatively stable in black men.49 In the PDAY Study, white and black young men have similar prevalence and mean extent of raised lesions in the right coronary artery. The decrease in coronary lesions in white men that may have been occurring between the 1960s and 1970s does not seem to be continuing.

Determinants of Atherosclerosis. Another major objective of the PDAY Study was to examine the relationship of the risk factors for adult CHD to atherosclerosis in persons younger than 35 years.50 Studies begun in the 1980s showed that plasma lipoprotein concentrations, blood pressure, glucose tolerance, adiposity, and smoking habits were nearly as variable among children and adolescents as they were among adults.51-52 However, except for the reports of a few cases of precocious atherosclerosis and CHD in young persons with familial hypercholesterolemia,53 their relationship to atherosclerosis was unknown. A small number of cases from the Bogalusa Heart Study showed associations of atherosclerosis with serum lipoprotein levels and blood pressure.54-55

The PDAY investigators have shown that very low-density lipoprotein and low-density lipoprotein cholesterol concentrations were positively and high-density lipoprotein cholesterol concentrations were negatively associated with both fatty streaks and raised lesions.14, 16 Smoking was associated with both fatty streaks and raised lesions in the abdominal aorta and with the prevalence of raised lesions in the right coronary artery.14 Elevated glycohemoglobin levels were associated with a substantial excess of fatty streaks and raised lesions in the right coronary artery and a lesser excess of raised lesions in the aorta.12 Hypertension was associated with more extensive raised lesions but not with fatty streaks in both the aorta and right coronary artery.13 Body mass index was associated with more extensive raised lesions of the right coronary artery.13 Thus, not only does atherosclerosis begin in childhood, the risk factors for adult CHD and the other clinical syndromes resulting from atherosclerosis determine to a large degree its rate of progression.

Labarthe56 recently suggested emphasizing the prevention of cardiovascular risk factors with the idea that the risk factors would become rare in the population, a result leading to less common and less extensive early atherosclerosis. This concept implies (1) primordial prevention as conceived by Strasser,57 (2) an important focus on youth, (3) bridging of socially institutionalized gaps (childhood and adulthood, schools and workplace, pediatrics and adult medicine), (4) early markers for risk factors and retarding progression of risk factors, and (5) observational studies and intervention trials to determine effectiveness.56 The PDAY results provide compelling support for the validity of this concept. This observational evidence is all we will have until noninvasive methods capable of detecting early raised lesions are available. True primary prevention of atherosclerosis, as contrasted with primary prevention of clinically manifest atherosclerotic disease, must begin in childhood or adolescence.


AUTHOR INFORMATION
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Funding/Support: Grants were awarded by the National Heart, Lung, and Blood Institute, Rockville, Md, to Steffen Gay, MD (HL-33733); Edward J. Miller, PhD (HL-33728); Assad Daoud, MD, and Adriene S. Frank, PhD (HL-33765); Louis C. Smith, PhD (HL-33750); Robert W. Wissler, PhD, MD, Dragoslava Vesselinovitch, DVM, MS, Akio Komatsu, MD, PhD, Yoshiaki Kusumi, MD, Toshinori Oinuma, MD, Alyna Chien, MA, Alexis Demopoulos, MD, Gertrud Friedman, R. Timothy Bridenstine, MS, Robert J. Stein, MD, Robert H. Kirschner, MD, Manuela Bekermeier, ASCP, Blanche Berger, ASCP, and Laura Hiltscher, ASCP (HL-33740; HL-45715); Abel L. Robertson, Jr, MD, PhD, Robert J. Stein, MD, Edmund R. Donoghue, MD, Robert J. Buschmann, MD, and Yoshihisa Katsura, MD (HL-33758); Drs Strong, Malcom, and Newman, Margaret C. Oalmann, DrPH, Dr Tracy, Sulochana Y. Bhandaru, MD, MPH, Cynthia S. Zsembik, DeAnne G. Gibbs, and Dana A. Troxclair, MS (HL-33746; HL-45720); Wolfgang Mergner, MD, PhD, Catherine Cole, PhD, and J. Smialek, MD (HL-33752; HL-45693); A. Bleakley Chandler, MD, Raghunatha N. Rao, MD, D. Greer Falls, MD, Ross G. Gerrity, PhD, Benjamin O. Spurlock, Kalish B. Sharma, MD, and Joel S. Sexton, MD (HL-33772); Bruce M. McManus, MD, PhD, and Jerry W. Jones, MD (HL-33778); Dr Cornhill, William R. Adrion, MD, Patrick M. Fardel, MD, Brian Gara, MS, Mr Herderick, and Larry R. Tate, MD (HL-33760; HL-45694); James E. Hixson, PhD (HL-39913); Dr McMahan, Henry C. McGill, Jr, MD, Yolan Marinez, MA, and Thomas J. Prihoda, PhD (HL-33749; HL-45719); Renu Virmani, MD, James B. Atkinson, MD, PhD, and Charles W. Harlan, MD (HL-33770; HL-45718); and Singanallur N. Jagannathan, PhD, and James Frost, MD (HL-33748).

PDAY Investigators: Program director: Dr Strong, 1996 to date, and Robert W. Wissler, PhD, MD, 1985-1996; Steering Committee: Dr Cornhill; Henry C. McGill, Jr, MD; Drs McMahan and Malcom; Margaret C. Oalmann, DrPH; Dr Strong; Robert W. Wissler, PhD, MD. Participating centers, principal and coinvestigators: Departments of Medicine (Steffen Gay, MD) and Biochemistry (Edward J. Miller, PhD), University of Alabama, Birmingham; Albany Medical College, Albany, NY (Assad Daoud, MD, and Adriene S. Frank, PhD); College of Medicine, Baylor University, Houston, Tex (Louis C. Smith, PhD); University of Chicago, Chicago, Ill (Robert W. Wissler, PhD, MD, Dragoslava Vesselinovitch, DVM, MS, Akio Komatsu, MD, PhD, Yoshiaki Kusumi, MD, Toshinori Oinuma, MD, Alyna Chien, MA, Alexis Demopoulos, MD, Gertrud Friedman, R. Timothy Bridenstine, MS, Robert J. Stein, MD, Robert H. Kirschner, MD, Manuela Bekermeier, ASCP, Blanche Berger, ASCP, and Laura Hiltscher, ASCP); University of Illinois, Chicago (Abel L. Robertson, Jr, MD, PhD, Robert J. Stein, MD, Edmund R. Donoghue, MD, Robert J. Buschmann, MD, and Yoshihisa Katsura, MD); Medical Center, Louisiana State University, New Orleans (Drs Strong, Malcom, and Newman, Margaret C. Oalmann, DrPH, Dr Tracy, Sulochana Y. Bhandaru, MD, MPH, Cynthia S. Zsembik; DeAnne G. Gibbs, and Dana A. Troxclair, MS); University of Maryland, Baltimore (Wolfgang Mergner, MD, PhD, Catherine Cole, PhD, and J. Smialek, MD); Medical College of Georgia, Augusta (A. Bleakley Chandler, MD, Raghunatha N. Rao, MD, D. Greer Falls, MD, Ross G. Gerrity, PhD, Benjamin O. Spurlock, Kalish B. Sharma, MD, and Joel S. Sexton, MD); Medical Center, University of Nebraska, Omaha (Bruce M. McManus, MD, PhD, and Jerry W. Jones, MD); Ohio State University, Columbus (Dr Cornhill, William R. Adrion, MD, Patrick M. Fardel, MD, Brian Gara, MS, Mr Herderick, and Larry R. Tate, MD); Southwest Foundation for Biomedical Research, San Antonio, Tex (James E. Hixson, PhD); Health Science Center, University of Texas, San Antonio (Dr McMahan, Henry C. McGill, Jr, MD, Yolan Marinez, MA, and Thomas J. Prihoda, PhD); Vanderbilt University, Nashville, Tenn (Renu Virmani, MD, James B. Atkinson, MD, PhD, and Charles W. Harlan, MD); and Health Sciences Center, West Virginia University, Morgantown (Singanallur N. Jagannathan, PhD, and James Frost, MD).

Corresponding Author and Reprints: Jack P. Strong, MD, Department of Pathology, Box P5-1, Louisiana State University Medical Center, 1901 Perdido St, New Orleans, LA 70112 (e-mail: jstron{at}lsumc.edu).

Author Affiliations: Department of Pathology, Louisiana State University Medical Center, New Orleans (Drs Strong, Malcom, Tracy, and Newman); Department of Pathology, University of Texas Health Science Center, San Antonio (Dr McMahan); Biomedical Engineering Center, Ohio State University, Columbus (Mr Herderick); and Biomedical Engineering, Cleveland Clinic Foundation, Cleveland, Ohio (Dr Cornhill). A list of the PDAY Investigators appears at the end of this article.


REFERENCES
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

1. Wissler RW. USA multicenter study of the pathobiology of atherosclerosis in youth. Ann N Y Acad Sci. 1991;623:26-39. ISI | PUBMED
2. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Natural history of aortic and coronary atherosclerotic lesions in youth. Arterioscler Thromb Vasc Biol. 1993;13:1291-1298. FREE FULL TEXT
3. Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea. JAMA. 1953;152:1090-1093. FREE FULL TEXT
4. Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea. [landmark article]. JAMA. 1986;256:2859-2862. FREE FULL TEXT
5. Strong JP. Coronary atherosclerosis in soldiers. JAMA. 1986;256:2863-2866. FREE FULL TEXT
6. Strong JP, McGill HC Jr. The pediatric aspects of atherosclerosis. J Atheroscler Res. 1969;9:251-265. ISI | PUBMED
7. Strong JP. Atherosclerotic lesions. Arch Pathol Lab Med. 1992;116:1268-1275. ISI | PUBMED
8. Burke AP, Farb A, Malcom GT, Liang Y-H, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276-1282. FREE FULL TEXT
9. Strong JP, for the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Natural history and risk factors for early human atherogenesis. Clin Chem. 1995;41:134-138. FREE FULL TEXT
10. Wissler RW, Hiltscher L, Oinuma T, for the PDAY Research Group. The lesions of atherosclerosis in the young: from fatty streaks to intermediate lesions. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, Pa: Lippincott-Raven; 1996:475-489.
11. Wissler RW, Hiltscher L, Wahden M. Early evolution of coronary artery lesions in young people. In: Fuster V, ed.Syndromes of Atherosclerosis: Correlations of Clinical Imaging and Pathology. Armonk, NY: Futura Publishing Co Inc; 1996:65-80.
12. McGill HC, McMahan CA, Malcom GT, et al. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Arterioscler Thromb Vasc Biol. 1995;15:431-440. FREE FULL TEXT
13. McGill HC Jr, Strong JP, Tracy RE, et al. Relation of a postmortem renal index of hypertension to atherosclerosis in youth. Arterioscler Thromb Vasc Biol. 1995;15:2222-2228. FREE FULL TEXT
14. McGill HC Jr, McMahan CA, Malcom GT. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. Arterioscler Thromb Vasc Biol. 1997;17:95-106. FREE FULL TEXT
15. McGill HC Jr, McMahan CA, Tracy RE, et al. Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. Arterioscler Thromb Vasc Biol. 1998;18:1108-1118. FREE FULL TEXT
16. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. JAMA. 1990;264:3018-3024. FREE FULL TEXT
17. Guzman MA, McMahan CA, McGill HC Jr, et al. Selected methodologic aspects of the International Atherosclerosis Project. Lab Invest. 1968;18:479-497. ISI | PUBMED
18. Draper NR, Smith H. Applied Regression Analysis. New York, NY: John Wiley & Sons Inc; 1966.
19. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. New York, NY: Van Nostrand Reinhold Co; 1982.
20. Cornhill JF, Herderick EE, Stary HC. Topography of human aortic sudanophilic lesions. In: Liepsch DW, ed. Blood Flow in Large Arteries: Applications to Atherogenesis and Clinical Medicine: Monograph of Atherosclerosis Basel. Farmington, Conn: S Karger AG; 1990:13-19.
21. Cornhill JF, Herderick EE, and the PDAY Research Group. Arterial disease in young people. Am J Cardiol. 1993.
22. Cornhill JF, Herderick EE, Vince DG, et al. The clinical morphology of human atherosclerotic lesions. Wien Klin Wochenschr. 1995;107:540-543. ISI | PUBMED
23. Klotz O, Manning MF. Fatty streaks in the intima of arteries. J Pathol. 1911;16:211. FULL TEXT
24. Saltykow S. Jugendliche und beginnende Atherosklerose. Aetze. 1915;45:1047-1089.
25. Mönckeberg JG. Über die Atherosklerose der Kombattenten (nach Obduktionsbefunde). Zentralbl Herz Gefasskrankheiten. 1915;7:7-10.
26. Zinserling WD. Untersuchungen über Atherosklerose, I: über die Aortaverfettung bei Kindern. Virchows Arch. 1925;255:677-705. FULL TEXT
27. Zeek P. Juvenile atherosclerosis. Arch Pathol Lab Med. 1930;10:417-446.
28. Holman RL, McGill HC Jr, Strong JP, Geer JC. The natural history of atherosclerosis. Am J Pathol. 1958;34:209-235. ISI | PUBMED
29. Strong JP, McGill HC. The natural history of coronary atherosclerosis. Am J Pathol. 1962;40:37-49. ISI | PUBMED
30. Holman RL. Atherosclerosis: a pediatric nutrition problem. Am J Clin Nutr. 1961;9:565-569. FREE FULL TEXT
31. Strong JP, McGill HC Jr. The natural history of aortic atherosclerosis. Exp Mol Pathol. 1963;1(suppl):15-27.
32. McGill HC Jr. The Geographic Pathology of Atherosclerosis. Baltimore, Md: Williams & Wilkins; 1968.
33. McGill HC Jr. Fatty streaks in the coronary arteries and aorta. Lab Invest. 1968;18:560-564. ISI | PUBMED
34. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arterioscler Thromb Vasc Biol. 1989;9(suppl 1):19-32.
35. Stary HC. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J. 1990;11(suppl E):3-19. PUBMED
36. Montenegro MR, Eggen DA. Topography of atherosclerosis in the coronary arteries. Lab Invest. 1968;18:586-593. ISI | PUBMED
37. Robertson WB, Geer JC, Strong JP, McGill HC Jr. The fate of the fatty streak. Exp Mol Pathol. 1963;(suppl 1):28-39.
38. Geer JC, McGill HC Jr, Robertson WB, Strong JP. Histologic characteristics of coronary artery fatty streaks. Lab Invest. 1968;18:105-110.
39. Hata Y, Hower J, Insull W. Cholesteryl ester-rich inclusions from human aortic fatty streak and fibrous plaque lesions in atherosclerosis. Am J Pathol. 1974;75:423-456. ISI | PUBMED
40. Katz SS, Shipley GG, Small DM. Physical chemistry of the lipids of human atherosclerotic lesions. J Clin Invest. 1976;58:200-211. ISI | PUBMED
41. Bocan TMA, Guyton JR. Human aortic fibrolipid lesions. Am J Pathol. 1985;120:192-206.
42. Bocan TMA, Schifani TA, Guyton JR. Ultrastructure of the human aortic fibrolipid lesion. Am J Pathol. 1986;123:413-434. ABSTRACT
43. Guyton JR, Klemp KF. Transitional features in human atherosclerosis. Am J Pathol. 1993;143:1444-1457. ABSTRACT
44. Guyton JR, Klemp KF. Development of the atherosclerotic core region. Arterioscler Thromb Vasc Biol. 1994;14:1305-1314. FREE FULL TEXT
45. Tejada C, Strong JP, Montenegro MR, Restrepo C, Solberg LA. Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex. Lab Invest. 1968;18:509-526. ISI | PUBMED
46. Strong JP, Guzman MA, Tracy RE, Newman WP III, Oalmann MC. Is coronary atherosclerosis decreasing in the USA? Lancet. 1979;2:1294. ISI | PUBMED
47. Strong JP, Guzman MA. Decrease in coronary atherosclerosis in New Orleans. Lab Invest. 1980;43:297-301. ISI | PUBMED
48. Strong JP, Oalmann MC, Newman WP III, et al. Coronary heart disease in young black and white males in New Orleans. Am Heart J. 1984;108:747-759. FULL TEXT | ISI | PUBMED
49. Newman WP III, Guzman MA, Strong JP, et al. Secular trends in atherosclerotic lesions. Mod Pathol. 1988;1:109-113. ISI | PUBMED
50. Solberg LA, Strong JP. Risk factors and atherosclerotic lesions: a review of autopsy studies. Arterioscler Thromb Vasc Biol. 1983;3:187-198. FREE FULL TEXT
51. Clarke WR, Schrott HG, Leaverton PE, et al. Tracking of blood lipids and blood pressures in school age children. Circulation. 1978;58:626-634. FREE FULL TEXT
52. Webber LS, Srinivassan SR, Wattigney WA, et al. Tracking of serum lipids and lipoproteins from childhood to adulthood. Am J Epidemiol. 1991;133:884-899. FREE FULL TEXT
53. Sprecher DL, Schaefer EJ, Kent KM, et al. Cardiovascular features of homozygous familial hypercholesterolemia. Am J Cardiol. 1984;54:20-30. ISI | PUBMED
54. Newman WP III, Freedman DS, Voors AW, et al. Relationship of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa Heart Study. N Engl J Med. 1986;314:128-144.
55. Freedman DS, Newman WP III, Tracy RE, et al. Black-white differences in aortic fatty streaks in adolescence and early adulthood. Circulation. 1988;77:856-864. FREE FULL TEXT
56. Labarthe DR. Prevention of cardiovascular risk factors in the first place. J Epidemiol. 1996;6:S65-S69.
57. Strasser T. Reflections on cardiovascular diseases. Interdisc Sci Rev. 1978;3:225-230.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

February 24, 1999
JAMA. 1999;281(8):769-770.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

In Vivo Insulin Sensitivity and Lipoprotein Particle Size and Concentration in Black and White Children
Burns et al.
Diabetes Care 2009;32:2087-2093.
ABSTRACT | FULL TEXT  

ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research.
Redberg et al.
J Am Coll Cardiol 2009;54:1364-1405.
FULL TEXT  

ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease): Developed in Collaboration With the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research
WRITING COMMITTEE MEMBERS et al.
Circulation 2009;120:1296-1336.
FULL TEXT  

The Effect of Aerobic Training and Cardiac Autonomic Regulation in Young Adults
Sloan et al.
AJPH 2009;99:921-928.
ABSTRACT | FULL TEXT  

Apo-B/AI ratio identifies cardiovascular risk in childhood:The Australian Aboriginal Birth Cohort study
Sellers et al.
Diabetes and Vascular Disease Research 2009;6:94-99.
ABSTRACT  

Interactive Effects of Race and Depressive Symptoms on Calcification in African American and White Women
Lewis et al.
Psychosom. Med. 2009;71:163-170.
ABSTRACT | FULL TEXT  

Regional heterogeneity within the aorta: Relevance to aneurysm disease.
Ruddy et al.
J. Thorac. Cardiovasc. Surg. 2008;136:1123-1130.
ABSTRACT | FULL TEXT  

Impact of Increasing Adiposity in Hyperlipidemic Children
Miller et al.
CLIN PEDIATR 2008;47:679-684.
ABSTRACT  

Coronary CT Angiography Findings in Patients Without Coronary Calcification
Kelly et al.
Am. J. Roentgenol. 2008;191:50-55.
ABSTRACT | FULL TEXT  

Contribution of Macromolecular Structure to the Retention of Low-Density Lipoprotein at Arterial Branch Points
Kwon et al.
Circulation 2008;117:2919-2927.
ABSTRACT | FULL TEXT  

Preventing Heart Disease in the 21st Century: Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study
McGill et al.
Circulation 2008;117:1216-1227.
FULL TEXT  

Review: Early-onset type 2 diabetes mellitus: a condition with elevated cardiovascular risk?
Song
British Journal of Diabetes & Vascular Disease 2008;8:61-65.
ABSTRACT  

Recent Trends in the Prevalence of Coronary Disease: A Population-Based Autopsy Study of Nonnatural Deaths
Nemetz et al.
Arch Intern Med 2008;168:264-270.
ABSTRACT | FULL TEXT  

Review: Obesity and cardiometabolic syndrome in children
Velasquez-Mieyer et al.
Ther Adv Cardiovasc Dis 2007;1:61-81.
ABSTRACT  

Hormonal and Nutritional Effects on Cardiovascular Risk Markers in Young Women
Lawson et al.
J. Clin. Endocrinol. Metab. 2007;92:3089-3094.
ABSTRACT | FULL TEXT  

Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases
Oda et al.
Hum Mol Genet 2007;16:592-599.
ABSTRACT | FULL TEXT  

Intracoronary ultrasound examinations reveal significantly more advanced coronary atherosclerosis in people with type 1 diabetes than in age- and sex-matched non-diabetic controls
Larsen et al.
Diabetes and Vascular Disease Research 2007;4:62-65.
ABSTRACT  

Has Blood Pressure Increased in Children in Response to the Obesity Epidemic?
Chiolero et al.
Pediatrics 2007;119:544-553.
ABSTRACT | FULL TEXT  

Nitric Oxide and Peroxynitrite in Health and Disease
Pacher et al.
Physiol. Rev. 2007;87:315-424.
ABSTRACT | FULL TEXT  

Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia
De Michele et al.
Heart 2007;93:78-81.
ABSTRACT | FULL TEXT  

Prediction of Coronary Artery Calcium in Young Adults Using the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Risk Score: The CARDIA Study
Gidding et al.
Arch Intern Med 2006;166:2341-2347.
ABSTRACT | FULL TEXT  

Pathobiological Determinants of Atherosclerosis in Youth Risk Scores Are Associated With Early and Advanced Atherosclerosis
McMahan et al.
Pediatrics 2006;118:1447-1455.
ABSTRACT | FULL TEXT  

NICE guidelines for hyperlipidaemia in children and young people with type I diabetes: time for a rethink?
Hussain et al.
Arch. Dis. Child. 2006;91:545-545.
FULL TEXT  

Emergence of Novel Genetic Effects on Blood Pressure and Hemodynamics in Adolescence: The Georgia Cardiovascular Twin Study
Kupper et al.
Hypertension 2006;47:948-954.
ABSTRACT | FULL TEXT  

Chemokines in Children With Heterozygous Familiar Hypercholesterolemia: Selective Upregulation of RANTES
Holven et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:200-205.
ABSTRACT | FULL TEXT  

In-Hospital Initiation of Statin Therapy in Acute Coronary Syndromes: Maximizing the Early and Long-term Benefits
Fonarow
Chest 2005;128:3641-3651.
ABSTRACT | FULL TEXT  

Socioeconomic Position, Cognitive Function, and Clustering of Cardiovascular Risk Factors in Adolescence: Findings From the Mater University Study of Pregnancy and Its Outcomes
Lawlor et al.
Psychosom. Med. 2005;67:862-868.
ABSTRACT | FULL TEXT  

Endothelial Progenitor Cell Therapy for Atherosclerosis: The Philosopher's Stone for an Aging Population?
Kravchenko et al.
Sci Aging Knowl Environ 2005;2005:pe18-pe18.
ABSTRACT | FULL TEXT  

Elevated Serum C-Reactive Protein Levels and Advanced Atherosclerosis in Youth
Zieske et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:1237-1243.
ABSTRACT | FULL TEXT  

Vascular consequences of menopause and hormone therapy: Importance of timing of treatment and type of estrogen
Dubey et al.
Cardiovasc Res 2005;66:295-306.
ABSTRACT | FULL TEXT  

Risk Scores Predict Atherosclerotic Lesions in Young People
McMahan et al.
Arch Intern Med 2005;165:883-890.
ABSTRACT | FULL TEXT  

Commentary: Incubation of coronary heart disease--recent developments
McCarron and Davey Smith
Int J Epidemiol 2005;34:248-250.
FULL TEXT  

Does shear stress modulate both plaque progression and regression in the thoracic aorta?: Human study using serial magnetic resonance imaging
Wentzel et al.
J Am Coll Cardiol 2005;45:846-854.
ABSTRACT | FULL TEXT  

Thematic review series: The Immune System and Atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis
Tobias and Curtiss
J. Lipid Res. 2005;46:404-411.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy and Cardiovascular Disease: What Went Wrong and Where Do We Go From Here?
Dubey et al.
Hypertension 2004;44:789-795.
ABSTRACT | FULL TEXT  

Sex-specific changes in platelet aggregation and secretion with sexual maturity in pigs
Jayachandran et al.
J. Appl. Physiol. 2004;97:1445-1452.
ABSTRACT | FULL TEXT  

Impaired Endothelial Function in Young Women with Premature Ovarian Failure: Normalization with Hormone Therapy
Kalantaridou et al.
J. Clin. Endocrinol. Metab. 2004;89:3907-3913.
ABSTRACT | FULL TEXT  

Childhood Socioeconomic Circumstances and Cause-specific Mortality in Adulthood: Systematic Review and Interpretation
Galobardes et al.
Epidemiol Rev 2004;26:7-21.
FULL TEXT  

Insulin Resistance Syndrome in Children
Ten and Maclaren
J. Clin. Endocrinol. Metab. 2004;89:2526-2539.
ABSTRACT | FULL TEXT  

Cardiovascular Risk Reduction in Preschool Children: The "Healthy Start" Project
Williams et al.
J. Am. Coll. Nutr. 2004;23:117-123.
ABSTRACT | FULL TEXT  

Diagnostic and Treatment Decisions in US Healthcare
Kaplan et al.
J Health Psychol 2004;9:29-40.
ABSTRACT  

Peroxisome proliferator-activated receptors as therapeutic targets in inflammation
Plutzky
J Am Coll Cardiol 2003;42:1764-1766.
FULL TEXT  

Starting Earlier to Prevent Heart Disease
McGill and McMahan
JAMA 2003;290:2320-2322.
FULL TEXT  

Effect of puberty on coronary arteries from female pigs
Chatrath et al.
J. Appl. Physiol. 2003;95:1672-1680.
ABSTRACT | FULL TEXT  

Acute coronary syndromes, plaque vulnerability,and carotid artery disease: The changing role ofatherosclerosis imaging
Tuzcu and Schoenhagen
J Am Coll Cardiol 2003;42:1033-1036.
FULL TEXT  

Endothelium-dependent responses in coronary arteries are changed with puberty in male pigs
Chatrath et al.
Am. J. Physiol. Heart Circ. Physiol. 2003;285:H1168-H1176.
ABSTRACT | FULL TEXT  

Management of Dyslipidemia in Children and Adolescents With Diabetes
American Diabetes Association
Diabetes Care 2003;26:2194-2197.
FULL TEXT  

Medical Management of Hyperlipidemia/Dyslipidemia
Kreisberg and Oberman
J. Clin. Endocrinol. Metab. 2003;88:2445-2461.
FULL TEXT  

Early-onset peripheral arterial occlusive disease: clinical features and determinants of disease severity and location
Barretto et al.
Vasc Med 2003;8:95-100.
ABSTRACT  

Long-term follow-up of coronary artery disease presenting in young adults
Cole et al.
J Am Coll Cardiol 2003;41:521-528.
ABSTRACT | FULL TEXT  

Understanding the Divergent Data on Postmenopausal Hormone Therapy
Grodstein et al.
NEJM 2003;348:645-650.
FULL TEXT  

The prevalence and severity of coronaryartery calcification on coronary arterycomputed tomography in black and white subjects
Lee et al.
J Am Coll Cardiol 2003;41:39-44.
ABSTRACT | FULL TEXT  

Carotid Artery Intimal-Medial Thickness and Left Ventricular Hypertrophy in Children With Elevated Blood Pressure
Sorof et al.
Pediatrics 2003;111:61-66.
ABSTRACT | FULL TEXT  

References
Circulation 2002;106:3373-3421.
FULL TEXT  

Commentary: The epidemiology of self-deprecation
Nieto
Int J Epidemiol 2002;31:1124-1127.
FULL TEXT  

Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Trial With Simvastatin
de Jongh et al.
Circulation 2002;106:2231-2237.
ABSTRACT | FULL TEXT  

Lipid Accumulation in Smooth Muscle Cells Under LDL Loading Is Independent of LDL Receptor Pathway and Enhanced by Hypoxic Conditions
Wada et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:1712-1719.
ABSTRACT | FULL TEXT  

Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial
Huang et al.
Am. J. Clin. Nutr. 2002;76:549-555.
ABSTRACT | FULL TEXT  

Infant Feeding and Blood Cholesterol: A Study in Adolescents and a Systematic Review
Owen et al.
Pediatrics 2002;110:597-608.
ABSTRACT | FULL TEXT  

Racial Differences in Coronary Artery Calcification in Older Adults
Newman et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:424-430.
ABSTRACT | FULL TEXT  

Lipids and Atherosclerosis: Lessons Learned from Randomized Controlled Trials of Lipid Lowering and Other Relevant Studies
Kreisberg and Oberman
J. Clin. Endocrinol. Metab. 2002;87:423-437.
FULL TEXT  

"Healthy-Start": Outcome of an Intervention to Promote a Heart Healthy Diet in Preschool Children
Williams et al.
J. Am. Coll. Nutr. 2002;21:62-71.
ABSTRACT | FULL TEXT  

Prevention of Coronary Artery Disease Should Start in the Young
Cheng
Circulation 2001;104 :e107-e107.
FULL TEXT  

Educational Attainment and Coronary and Aortic Calcification in Postmenopausal Women
Gallo et al.
Psychosom. Med. 2001;63:925-935.
ABSTRACT | FULL TEXT  

Prevalence and Correlates of Coronary Calcification in Black and White Young Adults : The Coronary Artery Risk Development in Young Adults (CARDIA) Study
Bild et al.
Arterioscler. Thromb. Vasc. Bio. 2001;21:852-857.
ABSTRACT | FULL TEXT  

Inhibition of Postmenopausal Atherosclerosis Progression: A Comparison of the Effects of Conjugated Equine Estrogens and Soy Phytoestrogens
Clarkson et al.
J. Clin. Endocrinol. Metab. 2001;86:41-47.
ABSTRACT | FULL TEXT  

Human Tissue Research in the Genomic Era of Medicine: Balancing Individual and Societal Interests
Ashburn et al.
Arch Intern Med 2000;160:3377-3384.
ABSTRACT | FULL TEXT  

Prospective, Randomized, Infancy-Onset Trial of the Effects of a Low-Saturated-Fat, Low-Cholesterol Diet on Serum Lipids and Lipoproteins Before School Age : The Special Turku Coronary Risk Factor Intervention Project (STRIP)
Rask-Nissila et al.
Circulation 2000;102:1477-1483.
ABSTRACT | FULL TEXT  

Emerging relations between infectious diseases and coronary artery disease and atherosclerosis
Fong
CMAJ 2000;163:49-56.
ABSTRACT | FULL TEXT  

Awareness, Perception, and Knowledge of Heart Disease Risk and Prevention Among Women in the United States
Mosca et al.
Arch Fam Med 2000;9:506-515.
ABSTRACT | FULL TEXT  

Lessons From Sudden Coronary Death : A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions
Virmani et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:1262-1275.
FULL TEXT  

Concepts of Time in Clinical Research
Samet
ANN INTERN MED 2000;132:37-44.
ABSTRACT | FULL TEXT  

Prevalence of coronary atherosclerosis in asymptomatic population
Widimsky and Andel
Eur Heart J 2000;21:13-14.
 

Progressing From Disease Prevention to Health Promotion
Peterson et al.
JAMA 1999;282:1812-1813.
FULL TEXT  

Effect of trans fatty acids on calcium influx into human arterial endothelial cells
Kummerow et al.
Am. J. Clin. Nutr. 1999;70:832-838.
ABSTRACT | FULL TEXT  

The Role of Dietary Fat in Child Nutrition and Development: Summary of an ASNS Workshop
Milner and Allison
J. Nutr. 1999;129:2094-2105.
FULL TEXT  

Assessment of Self-Reported Anger Expression in Youth
Musante et al.
Assessment 1999;6:225-233.
ABSTRACT  

Early Atherosclerosis Present in Virtually All Americans
Journal Watch Dermatology 1999;1999:16-16.
FULL TEXT  

Early Atherosclerosis Present in Virtually All Americans
JWatch General 1999;1999:7-7.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.